While society watches athletes and artists on a screen during the COVID-19 pandemic, some proponents tout ‘normalcy’ as the moment live in-action play resumes again. However, when we ‘see’ these athletes, are we truly seeing them? Failing to understand and address athletes’ adversity faced during this pandemic amidst social pressures to return to play under a preconceived notion of ‘normal’ commoditises athletes; instead, we must humanise them while recognising additional burdens they bear amidst unmet healthcare needs. Athletes and performers represent a unique population; they stand at the intersection of racial and socioeconomic health inequity and societal expectations for entertainment. Returning to the field or stage suddenly, unscathed by effects of global viral and racial pandemics, is impossible. Instead, athletes face resuming play with a sobering realisation the pursuit of health is not fulfilled with the same tenacity for everyone. This editorial is to raise awareness to disparities that exist for athletes and performing artist athletes during the COVID-19 pandemic and beyond.

中文翻译：

---

流行病中使用的运动员药物：运动员和表演者之间的差异表明医疗保健需要真正的“革命”

尽管在COVID-19大流行期间，社会在屏幕上观看运动员和艺术家，但当现场表演再次恢复时，一些支持者却吹捧“正常”。但是，当我们“看到”这些运动员时，我们是否真的看到了他们？在社会压力下，人们以一种“正常”商品运动员的先入为主的观念重返比赛，因此未能了解和解决运动员在大流行期间所面临的困境；取而代之的是，我们必须人性化，同时要认识到在未满足的医疗需求中他们承担的额外负担。运动员和表演者代表着独特的人群；他们处于种族和社会经济健康不平等与社会对娱乐的期望的交集处。不受全球病毒和种族大流行的影响而突然回到野外或舞台是不可能的。反而，运动员面对恢复比赛时有着清醒的认识，对健康的追求并不是每个人都一样坚韧。这篇社论旨在提高人们对COVID-19大流行及以后流行期间运动员和表演艺术家运动员之间差距的认识。